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Health Record-Derived Database
Michelle Mocarski, MPH,1 Ye Tian, PhD, MPH,1 B. Gabriel Smolarz, MD, MS,1
John McAna, PhD, MA,2 and Albert Crawford, PhD, MBA, MSIS2
Abstract
Obesity is a potentially modifiable risk factor for many diseases, and a better understanding of its impact on
health care utilization, costs, and medical outcomes is needed. The ability to accurately evaluate obesity
outcomes depends on a correct identification of the population with obesity. The primary objective of this study
was to determine the prevalence and accuracy of International Classification of Diseases, Ninth Revision (ICD-
9) coding for overweight and obesity within a US primary care electronic health record (EHR) database
compared against actual body mass index (BMI) values from recorded clinical patient data; characteristics of
patients with obesity who did or did not receive ICD-9 codes for overweight/obesity also were evaluated. The
study sample included 5,512,285 patients in the database with any BMI value recorded between January 1,
2014, and June 30, 2014. Based on BMI, 74.6% of patients were categorized as being overweight or obese, but
only 15.1% of patients had relevant ICD-9 codes. ICD-9 coding prevalence increased with increasing BMI
category. Among patients with obesity (BMI ‡30 kg/m2), those coded for obesity were younger, more often
female, and had a greater comorbidity burden than those not coded; hypertension, dyslipidemia, type 2 diabetes
mellitus, and gastroesophageal reflux disease were the most common comorbidities. Key findings: US outpa-
tients with overweight or obesity are not being reliably coded, making ICD-9 codes undependable sources for
determining obesity prevalence and outcomes. BMI data available within EHR databases offer a more accurate
and objective means of classifying overweight/obese status.
Keywords: obesity coding, electronic health records, prevalence
Introduction
Obesity has become one of the most important publichealth challenges of the modern era. Globally, the
prevalence of obesity has grownat an alarming rate over recent
decades, and it has more than doubled since 1980.1 Data from
the National Health andNutrition Examination Survey, 2011–
2012, showed that more than one third of adults in the United
States – more than 78 million individuals – were obese, with
the prevalence being higher in middle-aged than younger
adults.2 The medical consequences of obesity include mul-
tiple comorbidities such as type 2 diabetes mellitus, fatty
liver disease, hyperlipidemia, hypertension, coronary artery
disease, obstructive sleep apnea, and osteoarthritis, among
others,3–6 adding to the morbidity, mortality, and economic
burden of obesity.7–9 Given that obesity is a potentially mod-
ifiable risk factor, there is an urgent need to develop a greater
understanding of its relationships to other diseases and impact
on health care utilization, cost, andmedical outcomes. In other
disease states, this often is analyzed in the context of claims
data generated from International Classification of Diseases
(ICD) coding of primary diseases, complications, and inter-
ventions. However, if overweight and obesity are not reliably
coded in these databases, then the study of the subsequent
complications and interventionswill be limited and potentially
biased.
1Novo Nordisk, Inc., Plainsboro, New Jersey.
2College of Population Health, Thomas Jefferson University, Philadelphia, Pennsylvania.
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In order to study the nature and scope of obesity-related
complications, whether it be from a medical or payer per-
spective, it is critical that the population being studied is
identified accurately and completely for the findings to be
valid. Although medical claims data are well recognized as
useful for large-scale evaluations of disease epidemiology,
including medical and economic outcomes, previous re-
search has demonstrated that coding for obesity and body
mass index (BMI) in medical claims is inconsistent at best
and is significantly underrepresentative of populations with
overweight or obesity.10–16 The reasons are numerous, but it
is likely that ICD-9 coding for overweight and obesity is
often overlooked unless it is the primary reason patients are
seeking treatment. In addition, there are provider reim-
bursement challenges for obesity management, thus making
the reimbursement code alone not well suited to identifying
patients who may be overweight or obese.
Increased adoption of electronic health record (EHR)
technology by physicians in the United States is providing
a new source of health care data for outcomes research
purposes. Such data are based on information actually
measured during the routine process of patient care and
include biometric data, such as BMI, not available in
claims databases. The Quintiles electronic medical record
(EMR; QuintilesIMS, Durham, NC) research database is a
commercially-available, high-quality source of anonymized
patient-level ambulatory medical records. This database
captures a range of demographic and clinical variables, in-
cluding BMI, and is increasingly being used for outcomes
research pertaining to various disease states.17–22
The primary objective of this study was to determine the
prevalence and accuracy of ICD-9 coding for obesity and
overweight within the Quintiles EMR, compared to BMI
values calculated from patient data. The study also was de-
signed to analyze characteristics of patients with overweight
or obesity in the database (based on BMI values) who did or
did not receive ICD-9 codes for overweight or obesity. A
third objective was to examine whether the use of ICD-9
coding for overweight and obesity changed between 2011 and
2014.
Methods
Overall study design and data collection
This was a cross-sectional, 2-part analysis of data from a US
primary care EMR database, Quintiles EMR. The Quintiles
EMR database is used in the ambulatory care setting, with
more than 1300 sites in 49 states. There are more than 30,000
clinicians using the system, resulting in approximately 35
million patients in the database. Source data for the Quintiles
EMR database are captured with the GE Centricity (GE
Healthcare, Chicago, IL) user interface. Participating physi-
cians are in middle- to large-size group practices, with ap-
proximately 85% being primary care providers (eg, family
practice, internal medicine, obstetrics/gynecology, pediatrics).
Geographic areas served by the Quintiles EMR database are
similar to the overall US population and demographic char-
acteristics are similar to utilizers of health care in the National
Ambulatory Medical Care Survey.23 This database may or
may not document care provided in other health care sectors,
such as inpatient services and procedures (eg, imaging, same-
day surgery, acute rehabilitation, long-term care).
Demographic data collected from the Quintiles EMR da-
tabase included patient age, sex, race, and geographic region
of the United States. BMI measurements were determined
from actual patient height and weight values in the database
as input by clinical staff. Weight category classifications
(underweight, normal, overweight, Class I-III Obesity) were
based on BMI cutoffs set by the National Heart, Lung, and
Blood Institute. These analyses were limited to adult patients
aged 20 years and older.
ICD-9 codes are comprised of 3, 4, or 5 digits, with the first
3 digits being mandatory. Greater specificity is achieved by
the addition of 1 or 2 additional digits following a decimal
place. The following ICD-9 codes for overweight/obesity
were used in this study: 278 (Overweight, obesity and other
hyperalimentation); 278.0 (Overweight and obesity); 278.00
(Obesity unspecified); 278.01 (Morbid obesity); ICD-9
278.02 (Overweight); and 278.03 (Obesity hypoventilation
syndrome). Patients with claims evidence of pregnancy or
gestational diabetes were not included because of expected
BMI fluctuations related to pregnancy.
Part I: Prevalence and characteristics of patients receiving
ICD-9 codes for overweight/obesity. The primary analysis
was a point-in-time assessment of the prevalence of ICD-9
coding for patients with overweight and obesity in the
Quintiles EMR database and comparative characteristics
of coded versus non-coded groups. The inclusion criteria
for patients included in this analysis were: available BMI
measurement in the Quintiles EMR database between
January 1, 2014, and June 30, 2014; ‡20 years of age on
index date; no evidence of pregnancy or gestational dia-
betes; and at least 3 months of follow-up data after the
index BMI (first recorded BMI during the study period)
to provide an adequate time window for capturing ICD-9
coding.
All 3-month pre-index and 3-month post-index medical
records were searched for ICD-9 codes for overweight and
obesity. The rationale for searching 3 months before and
after the index BMI was to search for a sufficiently long
interval for the provider to have responded to the patient’s
increased weight, but not so long that the patient’s weight
was likely to have changed substantially. The proportions of
patients coded for overweight and obesity by ICD-9 codes
were compared with the proportions of patients in corre-
sponding weight categories based on actual height and
weight measurements. Among patients with BMI-categorized
obesity (BMI ‡30kg/m2), characteristics of age, sex, race,
region of the United States, and comorbidities were com-
pared between subgroups with and without ICD-9 codes for
overweight/obesity. Comorbidities were determined based on
ICD-9 codes. The Charlson comorbidity index (CCI), a
method widely used to measure the burden of comorbid
disease and predict mortality,24 was calculated. This index
consists of a list of 17 diagnoses and assigns a weight from 1
to 6 to each diagnosis. The summary score is the sum of
weighted values.
Descriptive statistics for all study variables were calcu-
lated. Categorical variables are described using the propor-
tion of patients in each category, and continuous variables
are described using mean and standard deviation. Logistic
regression was conducted to obtain odds ratios (ORs) for
receiving an ICD-9 code for overweight or obesity.
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Part II: Coding trends over time. This analysis compared
4 sequential years of coding patterns using data from Jan-
uary 1, 2011, to September 30, 2014. Patients for whom
index BMI values were available during each calendar
year (2011–2014) were grouped into conventional BMI
categories, and the database searched for any ICD-9 codes
for obesity or overweight over the whole year. The annual
prevalence of coding was examined by BMI category and
compared across the years. This analysis was performed on
all patients with BMI data, and for male and female subsets
separately.
Results
Part I: Prevalence and characteristics of patients
receiving ICD-9 codes for overweight/obesity
The study sample for this analysis included 5,512,285
patients with any BMI value recorded between January 1,
2014, and June 30, 2014. According to BMI values, 74.6%
of the study cohort had a BMI ‡25.0 and thus were eligible
to be coded for overweight or obesity. However, only 15.1%
of all patients (n = 833,763) had ICD-9 codes for overweight
or obesity.
The most commonly used ICD-9 code was 278.00
(Obesity, unspecified) in 10.6% of patients, followed by
278.02 (Overweight) in 2.6% of patients, and 278.01
(Morbid obesity) in 2.5% of patients. Codes 278.0 (Over-
weight and obesity), 278 (Overweight, obesity, and other
hyperalimentation), and 278.03 (Obesity hypoventilation
syndrome) were each used in <1% of patients.
Overweight and obesity coding by BMI category. Of all
patients with an ‘‘overweight’’ BMI (25.0–29.9 kg/m2; 32.3%
of the population), 3.86% were correctly coded for over-
weight only, 2.79% were incorrectly coded for obesity only,
and 0.19% coded for both obesity and overweight (Table 1).
Of all patients with an ‘‘obese’’ BMI (‡30.0 kg/m2; 42.3% of
the population), 27.3% were correctly coded for obesity only,
2.3% were incorrectly coded for overweight only, and 0.4%
were coded for both obesity and overweight.
The percentage of patients coded with an accurate ICD-9
code increased with increasing BMI category, with approxi-
mately two thirds of subjects in the highest BMI category
(‡50kg/m2) having a correct ICD-9 code for obesity (278.00,
Obesity, unspecified; 278.01, Morbid obesity; 278.03, Obe-
sity hypoventilation syndrome) and less than 1% of patients
in this BMI category having a code for overweight (278.02).
In the lowest BMI category for obesity (30–34.9 kg/m2), 17%
of patients were coded for obesity. The ICD-9 code for
morbid obesity (278.01) appeared to be applied most accu-
rately, with a majority (70.9%) of its use occurring in patients
with BMI ‡40kg/m2.
Table 2 presents the demographics of the subgroup of
study patients with an index BMI ‡30 kg/m2, as well as
comparative demographics for those coded for obesity and
those who were not. The patients who were coded for
obesity (28.0% of eligible patients), were younger, more
often female, and had a greater comorbidity burden com-
pared with patients not coded for obesity but who were
obese as assessed by actual BMI. Among patients with
BMI ‡30 kg/m2, the mean (–SD [standard deviation]) CCI
score was higher among patients coded for obesity than for
those not coded for obesity. Even among patients in the
highest CCI score category (5+), only 37% were coded for
obesity.
The mean BMI was significantly higher in the coded
versus the non-coded group, but it was still notably high in
the non-coded group (Table 2). Geographically, the highest
proportion of coded patients was observed in the Northeast
region of the United States. By race category, the highest
proportion of coding occurred among patients classified as
Native American and Multiethnic. White patients comprised
the greatest percentage of patients in the population with
BMI ‡30 kg/m2, yet the prevalence of obesity coding among
them was the lowest of the major racial groups evaluated.
Baseline characteristics for patients with an index BMI
of 25–29.9 kg/m2 and whether or not they were coded
for overweight are provided in online Supplementary
Table S1 (Supplementary Data are available online at www
.liebertpub.com/pop).
Table 1. Prevalence of Overweight/Obesity-Related Coding for Patients ‡20 Years Old
Within Body Mass Index Categories (for Patients Who Have Index Body Mass Index Measurements)
BMI category BMI (kg/m2)
Patients with
index BMI, n
(total N= 5,512,285)
ICD-9 coding for obesity/overweight,
n (% of patients in BMI category/row)
Diagnosis of
obesity onlya
Diagnosis of
overweight onlyb
Diagnosis of both
obesitya and overweightb
Underweight <18.5 72,683 352 (0.48) 76 (0.10) 10 (0.01)
Normal 18.5–24.9 1,324,866 4954 (0.37) 5434 (0.41) 199 (0.02)
Overweight 25.0–29.9 1,782,522 49,780 (2.79) 68,878 (3.86) 3475 (0.19)
Obese Class I 30.0–34.9 1,233,966 207,037 (16.78) 35,540 (2.88) 5295 (0.43)
Obese Class II 35.0–39.9 618,586 192,837 (31.17) 12,814 (2.07) 1933 (0.31)
Obese Class III 40.0–44.9 279,186 122,066 (43.72) 4239 (1.52) 943 (0.34)
45.0–49.9 117,668 62,435 (53.06) 1425 (1.21) 384 (0.33)
‡50.0 82,808 52,822 (63.79) 582 (0.70) 253 (0.31)
Shaded cells designate correct coding according to recorded BMI.
aICD-9 278 (Overweight, obesity and other hyperalimentation); ICD-9 278.0 (Overweight and obesity); ICD-9 278.00 (Obesity
unspecified), ICD-9 278.01 (Morbid obesity), ICD-9 278.03 (Obesity hypoventilation syndrome).
bICD-9 278.02 (Overweight).
BMI, body mass index; ICD-9, International Classification of Diseases, Ninth Revision.
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Coding and specific comorbidities. The most common
comorbidities among patients with a BMI ‡30 kg/m2 were
hypertension, dyslipidemia, type 2 diabetes mellitus, and
gastroesophageal reflux disease (Table 3). Among patients
coded for these comorbidities, the prevalence of obesity
coding concomitant with these diagnoses ranged from
32.5% to 36.9%.
In contrast, comorbidities such as Prader-Willi Syndrome,
metabolic syndrome, sleep apnea, nonalcoholic fatty liver
disease, and Cushing syndrome were coded much less fre-
quently (Table 3). However, patients with these comorbid
conditions were more likely to also be accurately coded for
obesity (44.3% to 55.4%).
Corresponding data for patients with an index BMI of 25–
29.9 kg/m2 (overweight) are provided in online Supple-
mentary Table S2.
Table 4 provides logistic regression model estimates for
probabilities of being coded for obesity according to de-
mographic and clinical characteristics. Younger adults had a
higher probability of being coded compared with older
adults, and female sex was associated with an OR of about
1.3 relative to male sex. Native American, Multiracial,
Hispanic, and black patients had higher ORs for being coded
relative to white patients. The probability of being coded for
obesity increased with increasing CCI category. Specific
comorbidities with the highest ORs included Prader Willi
Syndrome, metabolic syndrome, and sleep apnea.
Similar patterns were observed for coding of overweight
(online Supplementary Table S3), although CCI category
had much less influence on the probability of being coded.
The comorbidities with the highest ORs for overweight
coding were HIV, metabolic syndrome, and prediabetes.
Table 2. Baseline Characteristics Among Patients with Index Body Mass Index
‡30kg/m2 According to Obesity Coding Status
Patients with BMI ‡30 kg/m2
P valueaAll
Diagnosis of obesity,
N (% of row)
No diagnosis of
obesity, N (% of row)
Total, n 2,332,214 646,005 (28.0) 1,686,209 (72.0)
Age
Mean (SD) 54.9 (14.9) 53.2 (14.4) 55.6 (15.0) <.0001
Age group, n (%)
20–44 586,201 181,779 (31.0) 404,422 (69.0) <.0001
45–64 1,060,785 307,604 (29.0) 753,181 (71.0)
‡65 685,228 156,622 (22.9) 528,606 (77.1)
Sex, n (%)
Female 1,360,468 406,958 (29.9) 953,510 (70.1) <.0001
Male 971,652 239,022 (24.6) 732,630 (75.4)
Unknown 94 25 (26.6) 69 (73.4)
Race, n (%)
White 1,632,875 428,588 (26.2) 1,204,287 (73.8) <.0001
Black 260,012 89,401 (34.4) 170,611 (65.6)
Hispanic 44,037 16,680 (37.9) 27,357 (62.1)
Asian 18,608 4979 (26.8) 13,629 (73.2)
Native American 2378 1032 (43.4) 1346 (56.6)
Multi 10,107 4275 (42.3) 5832 (57.7)
Other 19,841 5484 (27.6) 14,357 (72.4)
Unknown/Undetermined 329,566 92,315 (28.0) 237,251 (72.0)
Not entered 14,790 3251 (22.0) 11,539 (78.0)
Region, n (%) <.0001
Midwest 464,053 125,369 (27.0) 338,684 (73.0)
Northeast 603,127 196,231 (32.5) 406,896 (67.5)
South 886,581 224,944 (25.4) 661,637 (74.6)
West 378,453 99,461 (26.3) 278,992 (73.7)
BMI, kg/m2
Mean (SD) 36.3 (6) 39.2 (7.2) 35.2 (5.0) <.0001
CCI Score
Mean (SD) 0.8 (1.3) 0.9 (1.4) 0.7 (1.2) <.0001
CCI Category, n (%)
0 1,371,705 334,202 (24.4) 1,037,503 (75.6) <.0001
1 526,363 169,846 (32.3) 356,517 (67.7)
2 216,336 65,589 (30.3) 150,747 (69.7)
3 109,954 37,108 (33.8) 72,846 (66.3)
4 50,735 18,378 (36.2) 32,357 (63.8)
5+ 57,121 20,882 (36.6) 36,239 (63.4)
aP values for coded vs non-coded patients; t test for continuous variables, chi-square test for categorical values.
BMI, body mass index; CCI, Charlson comorbidity index; SD, standard deviation.
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Part II: Coding trends over time
Among patients with BMI ‡30 kg/m2, the prevalence of
ICD-9 coding for obesity increased slightly each year from
2011 to 2014 (Fig. 1), with a slightly greater increase ap-
parent between 2013 and 2014 than between other years,
particularly within BMI categories ‡35 kg/m2. For all years,
the prevalence of coding for obesity was low, but it in-
creased as BMI category increased. Similar trends were
observed for both males and females, though the prevalence
of coding was consistently higher among women than men
(Table 5). Similar trends were observed for coding among
males and females even when analyzed by age categories
(data not shown).
Similar trends were observed for coding for overweight,
though coding for overweight was observed in very low
proportions of patients overall (online Supplementary
Fig. S1). Among patients with a BMI consistent with the
classification of overweight (BMI 25–29 kg/m2), the propor-
tion of patients with ICD-9 coding for overweight was very
low: 1.8% in 2011, 2.4% in 2012, 3.4% in 2013, and 3.9% in
2014. Prevalence of ICD-9 coding for overweight by year and
sex is provided in online Supplementary Table S4.
Discussion
This study provided a unique opportunity to examine the
prevalence and trends associated with clinician ICD-9 coding
for overweight and obesity based on actual patient BMI data.
Results demonstrate that ICD-9 codes should not be relied on
to estimate population prevalence rates of obesity or over-
weight, given the likelihood of capturing only a portion of
relevant patients and generating inaccurate conclusions about
the magnitude of the obesity problem. Furthermore, even in
other conditions where weight may be an effect modifier,
using ICD-9 codes for obesity/overweight will not provide an
effective control of confounding.
Even for patients in the very highest BMI categories of
40 kg/m2 and greater only one third to just over one half were
coded for obesity in any given year. Although the frequency
of coding for all categories of overweight or obesity increased
each year of the study, the overall frequency remained ex-
tremely low for such an important disease.
Interestingly, patients with obesity with rarely coded co-
morbidities such as Prader-Willi Syndrome, metabolic
syndrome, sleep apnea, nonalcoholic fatty liver disease, and
Cushing syndrome were the most likely to receive codes for
Table 3. Prevalence of Select Comorbidities and Obesity Coding Prevalence, Patients with Body Mass Index
‡30kg/m2 and Existing Comorbidities at Index Body Mass Indexa
Comorbidity n
Patients with BMI ‡30 kg/m2 (n = 2,332,214)
P valued
Comorbidityb
prevalence, %
Prevalence of
obesity codingc within
comorbidity category, %
Any CVD 1,161,465 49.8 31.3 <.0001
—Hypertension 991,773 42.5 32.5 <.0001
—Other CVD 588,676 25.2 29.6 <.0001
Dyslipidemia 933,876 40.0 32.8 <.0001
T2DM 454,757 19.5 36.9 <.0001
GERD 369,652 15.8 33.4 <.0001
Depression 307,436 13.2 36.9 <.0001
Malignancy 285,811 12.3 28.9 <.0001
Osteoarthritis 278,303 11.9 31.0 <.0001
Vitamin D Deficiency 225,072 9.7 39.6 <.0001
Sleep Apnea 212,157 9.1 46.0 <.0001
Prediabetes 124,287 5.3 40.4 <.0001
Chronic Kidney Disease 108,881 4.7 34.3 <.0001
NAFLD 34,587 1.5 44.9 <.0001
Gallbladder Disease 32,212 1.4 35.9 <.0001
Metabolic Syndrome 18,325 0.8 52.2 <.0001
Dyspepsia 16,971 0.7 33.6 <.0001
Inflammatory Bowel Disease 13,352 0.6 23.5 <.0001
HIV 6242 0.3 31.8 <.0001
Acute/Chronic Pancreatitis 5765 0.2 29.1 0.0143
Anorexia 1788 0.1 25.0 0.0108
Cushing Syndrome 828 0.04 44.3 <.0001
Feeding Difficulties 117 0.005 23.1 0.2653
Prader-Willi Syndrome 92 0.004 55.4 <.0001
Cachexia 50 0.002 18.0 0.1303
aIndex BMI= first recorded BMI measurement during the study period.
bComorbidity confirmed by existing diagnosis –3 month window around index BMI.
cICD-9 codes 278, 278.0, 278.00, 278.01, 278.03.
dP values for coded vs non-coded patients; t test for continuous variables, chi-square test for categorical variables.
BMI, body mass index; CVD, cardiovascular disease; GERD, gastroesophageal reflux disease; HIV, human immunodeficiency virus;
ICD-9, International Classification of Diseases, Ninth Revision; NAFLD, nonalcoholic fatty liver disease; T2DM, type 2 diabetes
mellitus.
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obesity. Among this group, Prader-Willi Syndrome and
Cushing Syndrome are epidemiologically uncommon, oc-
curring very rarely in any population and are specialist
treated. The fact that obesity is a core presentation of both of
these conditions may increase its likelihood for coding. In
contrast, the other comorbid conditions where obesity cod-
ing is common, such as metabolic syndrome, sleep apnea,
and nonalcoholic fatty liver disease are actually epidemio-
logically quite common; however, they are also commonly
underdiagnosed and, thus, likely to also be undercoded. In
the case where one of these comorbidities has been diag-
nosed and is being treated, coding alongside obesity coding
may not be surprising, as each of these comorbidities is
driven by obesity. Additionally, because it is not common to
code for these comorbidities or for obesity, it is possible that
there are particular clinicians who are more likely to either
assess these conditions and/or code for them. Surprisingly,
the rate of obesity coding was lower among other obesity-
driven comorbidities such as type 2 diabetes, hypertension,
and dyslipidemia. However, perhaps their high population
prevalence, in addition to the comorbid presentation of all 3,
does not provide an automatic trigger to clinicians to also
code for obesity.
Possible reasons for incomplete obesity and overweight
coding might include the time burden of documentation,
including prioritizing other codes in the limited time visit,
shortage of time to search for the code, lack of knowledge of
the existence of ICD codes for overweight and obesity, EHR
system issues wherein the codes do not come up in searches,
the limit of only 4 codes per procedure/visit (higher prior-
itization for ‘‘mainstream’’ diseases), and a nihilistic view
of coding weight status related to a perception or reality of
limited or no reimbursement for management of obesity,
because there currently is no increased payment or minimal
economic incentive to do so with many payers. It is also
worth noting that the data found an unexpected ‘‘false
positive’’ phenomenon in which a small percentage of pa-
tients with very low BMIs (<25 kg/m2) were coded as
overweight or obese, which could suggest a certain level of
operational or administrative error when it comes to coding
accuracy in general.
A lack of obesity coding behavior also may reflect a
general aversion among clinicians toward addressing the
topic of weight with their patients. Reasons for such be-
havior can include time limitations, failure to prioritize
obesity as a clinical issue, negative stereotypes and attitudes
about people with obesity, low levels of emotional rapport
with people with obesity, and poor expectations for weight
loss success.25–28 Some of these challenges may be ad-
dressed by improving health care provider training in weight
management.
Another likely phenomenon of the obesity epidemic is that,
as the mean BMI in the US has risen, patients with BMIs
>25kg/m2 (overweight) or >30kg/m2 (obese) are subcon-
sciously assessed as reflecting the norm rather than a popu-
lation at increased health risk that requires intervention. In
addition, clinicians are likely unaware of the biological basis
of obesity, and hence may be cynical about their ability to
facilitate weight loss. This is probably driven by past disap-
pointments with diet and exercise interventions or historic
failures of older weight loss medications. Data from the Na-
tional Ambulatory Medical Care Survey revealed a significant
decline in primary care physician-based weight counseling
efforts from 1995–1996 to 2007–2008 in the United States.29
This is an alarming trend, given the millions of individuals
with overweight/obesity, which has well-established health
consequences such as diabetes, heart disease, fatty liver, and
Table 4. Odds Ratios and 95% Confidence Intervals
from Logistic Regression Model Estimating
the Probability of Being Coded for Obesity,
Patients with Body Mass Index ‡30 kg/m2
Odds
ratio 95% CI P valuea
Demographic Characteristics
Age (ref = 65+)
20–44 1.937 1.917–1.956 <.0001
45–64 1.458 1.446–1.470 <.0001
Female (ref =Male) 1.339 1.329–1.348 <.0001
Race (ref =White)
Asian 0.988 0.955–1.021 <.0001
Black 1.438 1.424–1.452 <.0001
Hispanic 1.691 1.657–1.726 <.0001
Native American 2.173 1.999–2.362 <.0001
Multi 1.799 1.727–1.873 <.0001
Other 1.053 1.020–1.088 <.0001
Geographic Location (ref =West)
Midwest 1.048 1.036–1.060 0.0192
Northeast 1.253 1.240–1.267 <.0001
South 0.946 0.936–0.955 <.0001
Clinical characteristics
CCI Category (ref = 0)
1 1.226 1.215–1.236 <.0001
2 1.239 1.224–1.255 <.0001
3 1.420 1.396–1.444 <.0001
4 1.593 1.556–1.631 <.0001
5+ 1.713 1.671–1.757 <.0001
Comorbidities
Prader Willi Syndrome 2.245 1.417–3.556 0.0006
Metabolic Syndrome 2.194 2.124–2.267 <.0001
Sleep Apnea 2.164 2.141–2.186 <.0001
Prediabetes 1.523 1.503–1.544 <.0001
NAFLD 1.515 1.478–1.552 <.0001
Cushing Syndrome 1.366 1.170–1.596 <.0001
Vitamin D Deficiency 1.333 1.319–1.347 <.0001
T2DM 1.241 1.228–1.253 <.0001
Hypertension 1.237 1.228–1.247 <.0001
Dyslipidemia 1.211 1.202–1.221 <.0001
Depression 1.234 1.222–1.245 <.0001
Gallbladder Disease 1.170 1.140–1.201 <.0001
Osteoarthritis 1.078 1.068–1.089 <.0001
Feeding Difficulties 1.065 0.669–1.693 0.7913
Dyspepsia 1.036 0.998–1.075 0.0632
CVD 0.928 0.921–0.936 <.0001
Chronic Kidney Disease 0.910 0.894–0.926 <.0001
Malignancy 0.866 0.858–0.875 <.0001
Acute/Chronic
Pancreatitis
0.806 0.757–0.858 <.0001
Inflammatory
Bowel Disease
0.741 0.709–0.775 <.0001
Anorexia 0.740 0.658–0.832 <.0001
HIV 0.665 0.621–0.712 <.0001
Cachexia 0.440 0.191–1.015 0.0541
aFrom regression analysis.
CCI, Charlson comorbidity index; CI, confidence interval; CVD,
cardiovascular disease;HIV, human immunodeficiency virus;NAFLD,
nonalcoholic fatty liver disease; T2DM, type 2 diabetes mellitus.
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others, and the fact that overweight/obesity is a modifiable
risk factor.
A number of major changes have occurred in recent years
with potential impact on the medical coding environment in
the United States. The US Health Information Technology
for Economic and Clinical Health Act, passed in 2009,
provides financial incentives to hospitals and outpatient
clinics that utilize EHRs meeting certain requirements,
known as ‘‘meaningful use’’ standards. As part of these
standards, BMI calculations must be included in the EHRs.
Adoption of EHR compliance among outpatient providers
reportedly rose from 17% in 2006 to 78% in 2013.30 The
Affordable Care Act (ACA) went into full effect in January,
2014, providing millions of new patients access to the US
health care system overall, though adding additional ad-
ministrative burdens to medical practices as they adjust to
greater patient demand, multitudes of regulations, and adapt
to additional payer models. However, the ACA also has
strict documentation rules, reinforcing the need for medical
coding accuracy to avoid denial of reimbursement. The
current data noted a slight but noticeable increase in obesity
coding prevalence in 2014 relative to other years, most
evident among patients with BMI ‡35. Although this finding
coincides with the full implementation of the ACA in the
same calendar year, possible causal associations cannot be
determined. The ACA does require full coverage for pre-
ventive care obesity screening and counseling by most in-
surers, possibly increasing the financial incentive for
physicians to code and bill for weight-related services.
Further studies looking at coding trends over time will be
needed to evaluate the ongoing impact of the ACA and
Medicare and commercial payer quality reporting require-
ments on coding compliance and accuracy.
Another change affecting the US health care system, and
which the current data do not reflect, is the implementation
of the ICD-10 coding system in October 2015. The ICD-10
system represents a tremendous expansion of coding com-
plexity, as it contains approximately 72,000 diagnosis codes
FIG. 1. Prevalence of coding for obesitya by index body mass indexb category, by year, 2011 to 2014.c
aICD-9 codes (278, 278.0, 278.00, 278.01, 278.03) captured –3 months from date of index BMI in each year.
bIndex BMI =first recorded BMI measurement during the study period.
c2014 data reflect 9 months ( January – September).
BMI, body mass index; ICD-9, International Classification of Diseases, Ninth Revision.
Table 5. Prevalence of International Classficiation of Diseases, Ninth Revision Coding
for Obesitya by Index Body Mass Indexb by Year and Sex
BMI, kg/m2
% of patients with ICD-9 codes for obesitya
2011 2012 2013 2014
Females Males Females Males Females Males Females Males
25.0–29.9 2.4 1.3 2.5 1.5 2.7 1.6 3.3 2.0
30.0–34.9 12.1 9.8 13.2 10.7 15.2 12.4 17.9 14.4
35.0–39.9 23.7 23.3 24.5 23.8 26.4 25.2 30.4 28.8
40.0–44.9 34.7 36.7 35.0 36.6 36.5 37.9 41.4 42.2
45.0–49.9 43.4 47.9 43.3 46.6 44.7 48.2 49.8 52.5
‡50.0 54.5 58.9 54.2 58.1 55.1 58.7 59.9 63.4
aICD-9 codes 278, 278.0, 278.00, 278.01, 278.03.
bIndex BMI= first recorded BMI measurement during the study period.
BMI, body mass index; ICD-9, International Classficiation of Diseases, Ninth Revision.
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compared with 14,000 in the ICD-9 system. Previous nu-
meric ICD codes for diseases have been replaced with a
vastly expanded set of alphanumeric codes. Although the
intention is greater specificity and accuracy, it remains to be
seen if this new system will achieve the desired goals given
the much greater effort on behalf of the clinical team to
search, identify, and document these new codes. The present
data may provide a useful benchmark for future studies to
examine obesity coding trends with the ICD-10 system.
Previous US studies of varying methodology and sam-
ple size have reported under-recognition and poor coding
practices for obesity, including studies utilizing Medicare
records,31 the Mayo Clinic Rochester primary care data-
base,13 and US military health system EMRs.14 The present
data corroborate and expand on these prior findings, pro-
viding additional robust evidence from a multimillion pa-
tient sample with broad national representation of outpatient
coding practices in the United States. The present findings
add to a growing body of evidence substantiating the critical
limitations of relying on medical coding for tracking obesity
burden, epidemiology, expenditures, and outcomes.
Although not all providers will accept and enact the re-
quirement, as of January 2014 all health care providers in
the United States are now federally mandated to use EHR
systems. Hopefully, this will increase the scope and utility
of such databases for outcomes research, though it is un-
clear to what extent researchers will have access to these
improved data sets.
What should be equally concerning about these data is the
implication that if clinicians are not coding obesity, they likely
are not treating obesity13; prior research has revealed that
documentation of obesity correlates with interventional rec-
ommendations.32 Given that two thirds of the US population is
overweight or obese, the medical community needs to
proactively embrace treating overweight and obesity much as
they do for other chronic diseases such as depression or hy-
pertension. In fact, the magnitude of the problem represents a
tremendous opportunity for clinicians to make an impact on
numerous weight-related diseases simply by maintaining
awareness of obesity as a disease and being proactive in re-
commending evidence-based and effective weight-loss mea-
sures. Proactive physician communication, intervention, and
advice have been shown to be effective motivators for weight-
loss behavior,33 and medical therapy is often indicated.
Conclusions
This analysis found that patients with measured BMIs
indicating overweight or obese status in outpatient settings
in the United States still are not reliably coded in claims data
as such. Physicians, payers, and administrators who are
dedicated to evaluating medical and economic outcomes
related to obesity must be aware that medical coding data
for overweight and obesity are wholly inadequate for these
purposes. BMI determinations from clinical height and
weight data available within EHR databases are, in theory,
easily accessible and provide an accurate, objective means
of classifying overweight and obesity status. The apparent
high degree of discordant obesity coding may signal a need
for efforts to correct underlying perceptions and attitudes of
physicians regarding the medical relevance of obesity and
the need for effective intervention.
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